Home Page

EPA approved "Super Bug" Killer safe enough to apply to children's toys

Home Page

MRSA INFECTIONS...A GROWING PROBLEM:

There are now more deaths per year in the U.S. from MRSA infection than AIDS. The Centers for Disease Control and Prevention (CDC) estimates that in hospitals alone, there are 2 million health care-associated infections causing over 90,000 deaths annually, and a total cost that exceeds $30 Billion (average cost of $15,000 per occurrence).

"SUPERBUG" ATTACKS SCHOOLS & COMMUNITIES:

Multiple Studies have shown that rates of "Superbug" infection are growing fast and that the strains in the community may be more serious and difficult to treat than those encountered in health care settings (NIAID -National Institute of Allergy and Infectious Diseases')
Incidence in schools is on the rise...One study of children in south Texas found that cases of MRSA infection had a 14-fold increase over a 2 year period.
While health-care-associated MRSA infections more typically occur among the elderly, the average age of a person with a CA-MRSA infection is 23, due in large part to the number of infected children.

HOSPITALS NOT PREPARED FOR RESISTANT STRAINS:

More than 70% of the bacteria causing these infections are resistant to antibiotics.
Studies show that nearly 75% of patients’ rooms are contaminated with MRSA and 69% with VRE. (JAMA: Journal of the American Medical Association)
Potential financial impact to hospitals is huge, as CMS (Centers for Medicare and Medicaid Services) has published regulations which indicate that beginning in 2008, Medicare will not compensate hospitals for Hospital Acquired Infections (HAI) related claims because HAI’s are considered a hospital-preventable condition.

A SOLUTION EMERGES:

A year after leaving office as United States Secretary of Health & Human Services, Tommy G. Thompson, the former four term Governor of Wisconsin joined the Board of Directores of Pure Bioscience. Thompson was fully aware of the increasing dangers associated with viruses and bacteria that were building up anti-microbial resistance to many of the agents that were once effective. Once out of public office, Thompson spent a year working with scientists and entrepreneurs who were trying to address this public health threat. Thompson was introduced to the scientists and executives at Pure Bioscience and after a few months decided that the company's newly patented molecule "SDC" (Silver Di-Hydrogen Citrate; also refered to as AXEN-30 in the scientific community; sold as a hard surface disinfectant under the brand name Staphacide™) uniquely addressed the issue at hand and accepted a position as a member of the Board.

A LEADER TAKES CHARGE:

Secretary Thompson, considered by many to be an expert, has been informing and educating the public about MRSA and other hospital and community acquired infections for years. Thompson often points out that these hospital and community acquired diseases are preventable which is why he stridently believes that the current focus must shift from treatment to prevention. Thompson states "The emergence of resistant bacteria has changed the game for infectious disease control professionals, and an immediate solution must be implemented to contain the spread of MRSA and avoid a potential epidemic in our hospitals, schools and throughout our communities."

Frustrated by the increasing number of reported deaths and cases associated with MRSA as well as the lack of adopting a prevention strategy, Thompson formed a new company to address the issue head on. Thompson, Murphy, & Murtha LLC was formed to distribute Staphacide™(officially EPA registered brand under which SDC is marketed and sold).

As of January 1, 2008 Staphacide™ has been registered in all 50 States and TMM LLC is ready to distribute.